1. Home
  2. ATRC vs VERA Comparison

ATRC vs VERA Comparison

Compare ATRC & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRC
  • VERA
  • Stock Information
  • Founded
  • ATRC 2000
  • VERA 2016
  • Country
  • ATRC United States
  • VERA United States
  • Employees
  • ATRC N/A
  • VERA N/A
  • Industry
  • ATRC Medical/Dental Instruments
  • VERA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATRC Health Care
  • VERA Health Care
  • Exchange
  • ATRC Nasdaq
  • VERA Nasdaq
  • Market Cap
  • ATRC 1.6B
  • VERA 1.4B
  • IPO Year
  • ATRC 2005
  • VERA 2021
  • Fundamental
  • Price
  • ATRC $36.99
  • VERA $21.29
  • Analyst Decision
  • ATRC Strong Buy
  • VERA Buy
  • Analyst Count
  • ATRC 10
  • VERA 8
  • Target Price
  • ATRC $49.60
  • VERA $64.29
  • AVG Volume (30 Days)
  • ATRC 480.3K
  • VERA 1.8M
  • Earning Date
  • ATRC 10-28-2025
  • VERA 08-05-2025
  • Dividend Yield
  • ATRC N/A
  • VERA N/A
  • EPS Growth
  • ATRC N/A
  • VERA N/A
  • EPS
  • ATRC N/A
  • VERA N/A
  • Revenue
  • ATRC $499,946,000.00
  • VERA N/A
  • Revenue This Year
  • ATRC $16.32
  • VERA N/A
  • Revenue Next Year
  • ATRC $12.37
  • VERA N/A
  • P/E Ratio
  • ATRC N/A
  • VERA N/A
  • Revenue Growth
  • ATRC 16.28
  • VERA N/A
  • 52 Week Low
  • ATRC $25.24
  • VERA $18.53
  • 52 Week High
  • ATRC $43.11
  • VERA $51.61
  • Technical
  • Relative Strength Index (RSI)
  • ATRC 59.24
  • VERA 53.81
  • Support Level
  • ATRC $36.72
  • VERA $21.15
  • Resistance Level
  • ATRC $38.33
  • VERA $22.76
  • Average True Range (ATR)
  • ATRC 0.93
  • VERA 1.05
  • MACD
  • ATRC -0.02
  • VERA 0.16
  • Stochastic Oscillator
  • ATRC 60.82
  • VERA 62.11

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: